1Division for Experimental Perinatal Pathology, Department of Woman and Child Health, Karolinska Hospital, Stockholm, Sweden. bero@fafner.mb.ks.se
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Surfactant therapy is crucial for treating respiratory distress syndrome in newborns, with optimal outcomes depending on dose, timing, and delivery method. Novel artificial substitutes incorporating specific proteins show promise for future research.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: